As of October 2026, the scene at many pharmacy counters looks a lot like it did four years ago. A patient hands over a valid prescription, the pharmacist checks the shelf and the wholesaler system, and the answer is “we can’t get that strength right now.” The Adderall shortage that began in the fall of 2022 has not fully ended. On 21 October 2026, the FDA Drug Shortages Database still lists the immediate-release mixed amphetamine salts tablet (the generic form of Adderall) as “Currently in Shortage.”
That listing doesn’t mean every pharmacy is empty. Some strengths turn up, some manufacturers ship, and some patients fill without trouble. Others call five stores in a row. This guide explains why the Adderall shortage keeps hanging on, what the federal government has changed since 2022, and a practical, fully legal plan for keeping your treatment on track.
One note before we start: supply changes week to week. Treat this article as background, and check the FDA Drug Shortages Database for the latest status of the exact product you take.
Is there still an Adderall shortage in 2026?
Yes, based on what we could verify, the Adderall shortage 2026 patients are dealing with is real and official. The FDA’s database shows the immediate-release (IR) mixed amphetamine salts tablet as currently in shortage. Several related ADHD products also carry that label right now, including lisdexamfetamine capsules and chewable tablets (the generic form of Vyvanse) and some extended-release methylphenidate products.
For Adderall XR (extended-release capsules), the picture is murkier. When we checked, the FDA’s current list did not show a separate active entry for the extended-release capsule, yet patients and pharmacists continue to report spotty stock of certain XR strengths. If you take the XR version, do not assume it is easy to find. Look up your product in the FDA database and ask your pharmacy what its wholesaler is showing.
So the honest answer to “is there still an Adderall shortage” is this: the IR form is officially still short, related stimulants are short too, and availability varies a lot by strength, manufacturer, and region.
A short timeline of the shortage
The Adderall shortage did not happen all at once. The table below sticks to events we could confirm from FDA, DEA, Federal Register, and CDC records. It is not a complete list of every manufacturer delay.
| Year | What happened |
|---|---|
| 2022 | On October 12, the FDA publicly announced a shortage of immediate-release amphetamine mixed salts. It pointed to ongoing manufacturing delays at Teva and said other makers could not fully cover U.S. demand. |
| 2023 | In March, a CDC report showed stimulant prescription fills had climbed, with especially sharp increases among adults (and adult women in particular) during 2020–2021. In August, the FDA and DEA sent a joint public letter saying manufacturers had not produced their full allowed amount in 2022 and urging them to ramp up. That same month, two DEA rules took effect: one allowing patient-requested partial fills of Schedule II prescriptions, and one allowing a one-time electronic transfer of a controlled-substance prescription between pharmacies for the first fill. |
| 2024 | The DEA raised the 2024 production quota for lisdexamfetamine and for d-amphetamine used to make it, citing shortage concerns. The quota for d-amphetamine sold as finished product (the main Adderall-related category) stayed flat. |
| 2025 | The DEA raised lisdexamfetamine-related quotas again in September. In an order effective October 2, it increased the 2025 quota for d-amphetamine (for sale) by about 25 percent, from 21.2 million to 26.45 million grams, and raised methylphenidate (for sale) by about 9 percent. DEA records show the d-amphetamine (for sale) figure had been unchanged since at least 2021. In December, the DEA extended telehealth prescribing flexibilities for controlled medicines through December 31, 2026. |
| 2026 | The final 2026 quotas, effective January 5, kept d-amphetamine (for sale) at the higher 26.45 million gram level and raised the lisdexamfetamine and d-amphetamine (for conversion) quotas further. As of October 2026, the FDA still lists the IR mixed amphetamine salts tablet as currently in shortage. |
You can read the October 2025 quota change in full in the Federal Register notice on the 2025 d-amphetamine adjustment. The original FDA announcement from October 2022 is still posted as well.
Why is there an Adderall shortage? Why stimulant shortages happen
Most drug shortages have one or two causes. The Adderall shortage has several, and they stack on top of each other. Understanding them helps explain why the problem has lasted so long and why a quota increase alone did not fix it overnight.
The supply chain: from raw ingredient to your pharmacy shelf
Adderall is a blend of four amphetamine salts. Making it starts with the active pharmaceutical ingredient (API), the raw amphetamine material. A small number of companies produce that API. They sell it to dosage-form manufacturers, which press tablets or fill capsules. Those products then move through wholesalers to pharmacies.
Each step is a possible choke point. In 2022, the trigger was manufacturing delays at Teva, a major generic maker. When one large supplier slips, the others cannot simply double output. They need staff, production line time, quality testing, and, crucially, legal permission to buy more of the controlled raw material. A problem at one plant can ripple across the market for months, and that is roughly how the Adderall shortage started.
Business decisions matter too. Generic stimulants are low-margin products. If a company decides a certain strength isn’t worth producing, or shifts its line time to a more profitable drug, supply drops even if nothing went “wrong.” DEA filings from 2025 list rising demand, supply chain problems, manufacturing and quality issues, raw ingredient shortfalls, and company business choices as reasons manufacturers gave for shortages.
DEA production quotas
Because amphetamine is a Schedule II controlled substance, the DEA caps how much can be made in the U.S. each year. This is called the aggregate production quota (APQ). The DEA then divides that national cap among individual manufacturers. Companies must apply for their share and get permission to buy raw material.
The DEA adderall quota system exists to limit diversion and misuse. The trade-off is that the system reacts slowly. Quotas are set using estimates of medical need, and if real-world prescribing climbs faster than those estimates, there is no quick way to make more. Federal records show the d-amphetamine (for sale) quota stayed at 21.2 million grams from 2021 through 2024, during the very years prescribing rose sharply.
Still, the Adderall shortage isn’t as simple as “the DEA caused it.” In their August 2023 letter, the FDA and DEA said manufacturers had not used all of their allotted quota in 2022. In other words, some of the capacity that was legally allowed never became pills. Quotas, manufacturing problems, and business decisions all played a part.
The October 2025 increase to 26.45 million grams was the first change to that category in years. Higher limits help, but they take time to show up at the counter. Raw material has to be made, shipped, turned into tablets, tested, and distributed. A quota raised in the fall may not reach pharmacy shelves in meaningful amounts until well into the following year.
Demand growth: telehealth and adult diagnoses
Demand changed fast after 2020. A CDC analysis of stimulant prescription fills among commercially insured people found steady growth from 2016 to 2021, with a particularly steep rise in 2020–2021 among adults. Fills among women in their late teens through mid-40s climbed especially quickly.
Several things fed that growth. More adults were recognized as having ADHD, often after years of struggling without a diagnosis. Pandemic-era rules let clinicians prescribe controlled medicines over video without an in-person visit first, which made care easier to reach. Those telehealth flexibilities have been extended several times and are currently in place through the end of 2026. More access is good for many patients, but it also means more prescriptions competing for a supply that grew slowly.
When demand for one stimulant outpaces supply, patients and prescribers switch to others. That pushes the Adderall shortage sideways into other medicines. It’s part of why lisdexamfetamine and some methylphenidate products have also landed on the FDA shortage list.
Why one strength disappears while another stays
Many patients notice that their 20 mg tablets vanish while 10 mg tablets sit on the shelf, or the reverse. This is normal during a shortage, and it has a few explanations.
- Manufacturers make strengths in separate runs. A company may finish a batch of one strength and not return to another for weeks.
- Not every maker produces every strength. If the main producer of a certain dose has a delay, that dose dries up even when others are fine.
- Demand shifts in waves. When one strength is short, prescribers switch patients to a nearby dose, which then runs low too.
- Wholesaler allocation. Distributors may ration limited stock among pharmacies, so one store gets a few bottles and the next gets none.
The same logic explains why an Adderall XR shortage can hit one capsule size harder than others, and why brand-name and generic supplies don’t always move together.
What patients can do: a 9-step plan
You can’t fix the Adderall shortage on your own, but you can lower your odds of a gap in treatment. Each step below is legal and works best when you involve your prescriber and pharmacist early.
- Call pharmacies before you send the prescription. Pharmacists usually can’t promise stock over the phone for controlled medicines, but many will tell you whether they can order your exact product and strength. Independent pharmacies sometimes use different wholesalers than big chains, so include a few local, non-chain stores in your calls. Ask when their next shipment usually arrives.
- Ask about other strengths and manufacturers. If your 20 mg tablet is out, the pharmacy may have 10 mg tablets. With a new prescription from your prescriber, taking two 10 mg tablets can equal one 20 mg dose. Generics from different manufacturers contain the same active ingredients, though tablets may look different. Never switch strengths or doses on your own. The prescription has to match what you take.
- Understand partial fill rules. Since August 2023, federal rules let a patient (or the prescriber) ask a pharmacist to partially fill a Schedule II prescription. The rest can generally be filled within 30 days of the date the prescription was written, and the total can never exceed the amount prescribed. State laws and pharmacy policies vary, so ask your pharmacist how it works where you live. Partial fills can help when a store has some of your supply but not all of it.
- Ask about moving an unfilled e-prescription. A 2023 DEA rule allows a one-time electronic transfer of a controlled-substance prescription from one pharmacy to another for the first fill, if you request it and state law allows. If your pharmacy can’t fill it, ask whether it can transfer the prescription to a store that has stock. If not, your prescriber can cancel and resend it.
- Talk with your prescriber about switching between XR and IR. Sometimes one form is available when the other isn’t. IR tablets start working in about 30 to 60 minutes and last roughly 4 to 6 hours, so they are often taken more than once a day. XR capsules take about 1 to 2 hours to kick in and last around 10 to 12 hours. Changing forms changes your schedule, so this is a decision for your prescriber. Our guide to the differences between Adderall XR and IR walks through what to expect.
- Discuss adderall alternatives during shortage periods. Other ADHD medicines may be easier to find in your area. Options your prescriber may weigh include lisdexamfetamine (see our Vyvanse vs Adderall comparison), dextroamphetamine (how Dexedrine compares), methylphenidate products (Adderall vs Ritalin and Adderall vs Concerta), and non-stimulants such as atomoxetine (Strattera vs Adderall). Keep in mind that some of these are also short. Non-stimulants can take several weeks to reach full effect, so they work better as a planned switch than an emergency fix.
- Get insurance prior authorization started early. Switching to a new drug, a brand name, or a different form can trigger a prior authorization or step therapy rule. Ask your prescriber’s office to submit the paperwork as soon as a switch is on the table. If a generic is unavailable and your plan only covers the generic, ask the office to note the shortage in the request. Approval can take days, so don’t wait until your last pill.
- Plan refills early, within legal limits. Schedule II prescriptions can’t have refills, so each fill needs a new prescription. Federal rules allow a prescriber to write multiple prescriptions at once for up to a 90-day supply with “do not fill before” dates, where state law permits. Ask whether this is an option for you. Some insurers and pharmacies also allow a fill a few days before you run out. Mark your calendar about a week before your supply ends so you have time to make calls.
- Use the FDA shortage database and keep notes. Search the FDA Drug Shortages Database for “amphetamine” to see which products are listed and any manufacturer notes on expected availability. Keep a simple list of which pharmacies had stock, which manufacturer’s product you received, and when. That record helps you and your prescriber spot patterns and move faster next month.
If you’re new to treatment, our guide on how an ADHD evaluation and prescription work explains the steps. Ask your clinician at the start how they handle shortages, since many offices now have a standard plan.
What not to do
The Adderall shortage creates pressure, and pressure leads some people toward risky shortcuts. These are the ones that can cause real harm.
Never buy Adderall online without a prescription
Websites that sell “Adderall” without a prescription are not legitimate pharmacies. The DEA has warned about illegal online pharmacies selling counterfeit pills, many of them run from overseas while posing as U.S. or FDA-approved sites. Red flags include no prescription requirement, prices that seem too good to be true, foreign packaging, and no proof of a state pharmacy license. Real pharmacies that dispense Schedule II drugs always require a valid prescription.
Understand the danger of fake Adderall pills
Counterfeit pills made to look like Adderall have been found containing methamphetamine and fentanyl, according to DEA warnings. They can carry the right color, shape, and imprint and still contain something else entirely. Fentanyl is so potent that a tiny amount can be deadly. The DEA’s One Pill Can Kill campaign shows side-by-side photos of authentic and fake Adderall that are hard to tell apart by eye.
Pills from a friend, a dealer, a social media seller, or an unverified website carry this risk. There’s no safe way to test a pill’s contents at home with certainty. If someone around you may have taken a counterfeit pill and seems very drowsy, has slow or stopped breathing, or won’t respond, call 911. Our guide to naloxone and opioid safety explains how naloxone can reverse a fentanyl overdose.
Don’t share or borrow pills
Giving or selling your prescription stimulant to someone else is illegal and can be dangerous for them. A dose that is right for you may not be safe for a person with heart problems, high blood pressure, or certain other medications. Borrowing from someone else carries the same risks and can also make your own treatment harder to manage. Stimulants interact with a number of drugs, including MAOIs and some antidepressants, which is covered in our article on Adderall drug interactions.
Don’t ration without a plan from your prescriber
Skipping doses or splitting your supply to stretch it may seem sensible, but it can lead to uneven symptom control and confusion about what’s working. Some extended-release capsules should not be crushed or chewed. If you’re worried about running short, tell your prescriber. They may suggest a plan, such as reserving doses for workdays, that fits your situation safely.
If you run out
Despite your best efforts, the Adderall shortage may still leave you with days when you can’t fill your prescription. Here’s what to expect and what to do.
What it may feel like. When people stop a stimulant suddenly, ADHD symptoms usually return within a day or so, since the medicine doesn’t build up the way some drugs do. Many people also notice tiredness, low mood, increased appetite, irritability, trouble concentrating, or vivid dreams for a few days. These effects are generally more noticeable in people who have taken higher doses for a long time. For most patients, an unplanned gap is uncomfortable rather than dangerous. Our post on Adderall withdrawal symptoms and timeline covers this in more detail.
Call your prescriber right away. Don’t wait until you’ve been without medication for a week. Your prescriber may be able to send a prescription for a different strength, form, or medicine that a nearby pharmacy has in stock. Let them know which pharmacies you’ve already tried.
Protect your day. If you’re without medication, consider telling a manager, teacher, or school nurse that you’re dealing with a pharmacy shortage. Use reminders, lists, and timers for tasks you usually handle easily. Avoid driving if you feel unusually drowsy or unfocused.
Watch for warning signs. Get medical help promptly if low mood becomes severe or you have any thoughts of harming yourself. In the U.S., you can call or text 988 for the Suicide and Crisis Lifeline at any time.
Restart carefully. When you get your medication back, ask your prescriber or pharmacist how to restart. Usually you resume your normal dose, but if you were off for a long time or switched to a different product, your prescriber may want to adjust.
Frequently Asked Questions
Is there still an Adderall shortage?
Yes. As of October 2026, the FDA Drug Shortages Database lists the immediate-release mixed amphetamine salts tablet as currently in shortage. Availability varies by strength, manufacturer, and location, so some patients fill easily while others struggle. Check the FDA database for the latest on your specific product.
When will the Adderall shortage end?
No one can give a firm date for when the Adderall shortage will end. The FDA has not announced that it is resolved. The DEA raised the main amphetamine production quota in October 2025 and kept it at that higher level for 2026, which should help over time, but it takes months for added production to reach pharmacies.
Is there an Adderall XR shortage too?
Patients and pharmacies have reported gaps in some XR strengths throughout the Adderall shortage. When we checked the FDA database in October 2026, the main active entry was for IR tablets. XR supply can still be uneven in your area, so ask your pharmacist and check the database directly.
Did the DEA raise the Adderall quota?
Yes. In an order effective October 2, 2025, the DEA raised the 2025 quota for d-amphetamine (for sale) from 21.2 million to 26.45 million grams, about a 25 percent increase. The final 2026 quota kept that higher figure. The DEA also raised quotas tied to lisdexamfetamine in 2024, 2025, and 2026.
What are the best Adderall alternatives during a shortage?
There’s no single best option. Depending on your health history and what’s in stock, your prescriber may consider lisdexamfetamine, dextroamphetamine, methylphenidate products, or a non-stimulant like atomoxetine. Some of these are also in short supply, so your prescriber and pharmacist can help you choose something you can actually fill.
Can I fill my prescription at a different pharmacy if mine is out?
Often, yes. Since August 2023, federal rules allow a one-time electronic transfer of a controlled-substance prescription between pharmacies for the first fill, at your request, where state law allows. If that isn’t possible, your prescriber can cancel the original and send a new prescription to a pharmacy that has stock.
Are fake Adderall pills really dangerous?
Yes. The DEA has warned that counterfeit pills sold as Adderall may contain methamphetamine or fentanyl. They can look nearly identical to the real thing. Only take stimulants dispensed by a licensed pharmacy with your own prescription.
This article is for educational purposes only and is not medical advice. Drug shortage status changes often, so confirm current availability with the FDA Drug Shortages Database and your pharmacy. Talk with your prescriber or pharmacist before changing, stopping, or switching any medication.
